Assessment of region-specific oxidative stress in multiple sclerosis using short-TE STEAM at 7T

Characterization of White Matter Lesions in Multiple Sclerosis using Proton density and T1-relaxation Measures

Cross-Sectional and Longitudinal Evaluation of White Matter Microstructure Damages by Automated Fiber Quantification in Multiple Sclerosis

GABA and Glx levels in relapsing-remitting multiple sclerosis correlate with clinical disability

Increased Cerebral Lactate-to-Pyruvate Ratio in Primary Progressive Multiple Sclerosis using Hyperpolarized Pyruvate MRI.

Microstructure-Informed Susceptibility Source Separation (MI-SSS) for Improved Estimation of Neural Myelin and Iron Content

Quantitative Myelin Assessment for Multiple Sclerosis Using Multi-Inversion Magnetic Resonance Fingerprinting

Quantitative T2* Ferumoxytol MRI to Evaluate Activated Innate Immunity in Progressive Multiple Sclerosis

Resolution of glial activation in relapsing and primary progressive MS over 2 years with ocrelizumab: longitudinal MR spectroscopy study

Serum 24-Hydroxycholesterol is weakly correlated with brain water content, myelin water fraction and T1 relaxation in different stages of MS

Study of Neurometabolic Alterations in Multiple Sclerosis Using Fast High-Resolution 3D 1H-MRSI

Subdivisional Iron Deposition and Swallow Tail Sign of Substantia Nigra in RRMS Patients by Quantitative Susceptibility Mapping

To evaluate the degree of brain tissue damage in relapsing-remitting multiple sclerosis patients by using susceptibility weighted imaging

Towards precise quantification of chronic active MS lesions using submillimeter isotropic QSM with 3D-EPI at 3T